Multichannel
Pharma needs a digital reset
Pharma knows the value of digital, yet it admits only a fraction of launches regularly succeed
Multichannel
Pharma needs a digital reset
Just 4% of digital product launches regularly succeed, despite a strong industry appreciation of the value of digital. The...
Multichannel
Modularise to personalise
Digital engagement is now central to the way pharma connects with HCPs. Its urgent challenge is keeping its messaging relevant in a context...
Latest
-
-
Patients and Medical
Digital patient engagement data: Are you already falling behind?
Gathering and acting on insights from digital patient engagement data is becoming a competitive differentiator, yet many in pharma are still stuck in learning mode -
Commercial
The field force: Is small beautiful?
As big pharma ponders the right sizing of its post-pandemic field forces, can it learn from smaller, leaner industry peers about doing more with less? -
Access and Evidence
How automation is changing regulatory affairs
Post pandemic, pharma and regulators are both working to accelerate the transformative power of electronic filing -
Multichannel
Modularise to personalise
Digital-first engagement is challenging pharma to deliver content on HCPs’ terms and a modular approach is key
Most Popular
Andrew Stone, (May 31, 2022)
Pharma knows the value of digital, yet it admits only a fraction of launches regularly succeed
Andrew Stone, (May 10, 2022)
Gathering and acting on insights from digital patient engagement data is becoming a competitive differentiator, yet many in pharma are still stuck in learning mode
Andrew Stone, (May 5, 2022)
As big pharma ponders the right sizing of its post-pandemic field forces, can it learn from smaller, leaner industry peers about doing more with less?
Opinion
Jill Donahue, (Feb 13, 2022)
Paying it forward and helping others act on their patient-driven purpose is the goal of this pharma leader
Jill Donahue, (Jun 7, 2021)
Following in his physician father's footsteps, for this pharma leader it's always been about the patient
Commercial
-
The field force: Is small beautiful?
As big pharma ponders the right sizing of its post-pandemic field forces, can it learn from smaller, leaner industry peers about doing more with less? -
Cell & Gene Therapy: High stakes and high hopes for healthcare
Now that CGT is proving its worth, the next task for pharma is working out the best ways to commercialise it -
Unlocking the full potential of biosimilars
The future looks bright for biosimilars in an age of crisis over healthcare affordability -
Accelerating commercial success in CAGT
To build on the successes thus far in cell and gene therapy, pharma must foster further payer, physician and patient buy-in -
Blended and augmented: Reimagining the role of the rep
The events of 2020 have compelled pharma to reimagine the role of the rep to better adapt to the new rules of engagement
Access and Evidence
-
How automation is changing regulatory affairs
Post pandemic, pharma and regulators are both working to accelerate the transformative power of electronic filing -
An early peek at the FDA’s RWE ‘cookbook’
The FDA is developing guidelines that will help pharma accelerate its adoption of RWE, this is what the industry should know -
The future is bright for RWE in pharma approvals
The FDA and other regulatory bodies are increasingly willing to accept real-world evidence as part of approvals. Pharma is up to the task -
Payers and the ABCs of digital literacy
Convincing payers of the value of digital add-ons and of drug/device combinations requires pharma to demonstrate that patients and other stakeholders understand how to use them -
Decoding the patient journey with RWD
Patient real-world data contains a wealth of potentially valuable information for life sciences commercial teams, if they can filter out the noise
Patients and Medical
-
Patient services: a digital roadmap
Leveraging the full capabilities of digital will enable pharma to transform the patient experience -
Digital patient engagement data: Are you already falling behind?
Gathering and acting on insights from digital patient engagement data is becoming a competitive differentiator, yet many in pharma are still stuck in learning mode -
Reaching Gen-Z
Young people comprise a unique demographic that pharma is not used to serving but new digital tools offer ways to understand, engage and serve them better -
Helping patients help themselves
Self care offers a new way for health care companies to serve patients better globally and industry collaboration will drive faster progress -
Chiesi: Putting purpose at its heart
Italian pharma company Chiesi has embedded environmental and social purpose into its very corporate fabric
Latest Videos
Upcoming Events
View All EventsJuly 2022
-
FREE Webinar: Build a fully integrated omnichannel strategy to facilitate a cohesive company face
Jul 13, 2022 - Jul 13, 2022
September 2022
-
Cell & Gene Therapy USA 2022
Sep 20, 2022 - Sep 21, 2022
October 2022
-
Total Health USA 2022
Oct 4, 2022 - Oct 5, 2022
November 2022
-
Pharma Awards Europe 2022
Nov 17, 2022 - Nov 17, 2022